RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 34-44
  • Mylan ups bid again for Irish-based drug manufacturer Perrigo; Perrigo quickly says no

    PITTSBURGH Generic drug giant Mylan Wednesday morning boosted its offer for Irish-based drugmaker Perrigo for the second time, just two days after harshly rejecting an unsolicited takeover offer from Israel-based Teva Pharmaceutical Industries. Perrigo...
  • New meds help drugmakers weather strong dollar, other issues

    Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter...
  • Address drug abuse and access together: My Word

     Address drug abuse and access together: My Word
    In one household, a family is devastated by prescription-drug abuse. While in another, a patient can't understand why he is denied the pain medications needed to make life bearable. Both scenarios are heartbreaking, and different, but also tied...
  • Bristol-Myers earnings jump 27 percent, but stock falls

    Higher sales of key new medicines and cost cuts helped lift drugmaker Bristol-Myers Squibb Co.'s first-quarter profit by nearly 27 percent. The maker of melanoma drug Yervoy and schizophrenia and bipolar disorder treatment Abilify trounced Wall Street'...
  • Pfizer, despite dollar and generics fight, still impresses

    Cost-cutting and sales of new drugs helped Pfizer overcome a strong dollar and patent expirations to beat Wall Street projections for the first quarter, though it cut its outlook for the year, citing the unfavorable currency exchange rates. The world's...
  • Merck hurdles Wall Street forecasts

    Drugmaker Merck & Co. easily beat Wall Street expectations, sending its shares up sharply, despite first-quarter profit plunging 44 percent. Income was hurt by the sale of its consumer health business, unfavorable currency exchange rates and competition...
  • Hospira earnings rise 11 percent with Pfizer deal pending

    Hospira earnings rise 11 percent with Pfizer deal pending
    Injectable drugs company Hospira reported first-quarter 2015 results Tuesday that beat expectations. Pharmaceutical giant Pfizer offered to buy the Lake Forest company in February for about $15.23 billion. Here's a snapshot of the quarter, and a bit...
  • FDA deal sharply limits Medtronic infusion pump manufacturing, sales

    MINNEAPOLIS Medtronic has entered an agreement with the Food and Drug Administration to stop selling an infusion pump except in rare cases because the company failed to fix manufacturing problems that may cause the implantable devices to deliver too...
  • Mylan rejects Teva Pharmaceutical's takeover bid

    PITTSBURGH Mylan on Monday rejected Teva Pharmaceutical Industries' unsolicited takeover proposal, saying it "grossly undervalues" Mylan, would give Mylan shareholders "low-quality, high-risk" Teva stock, and expose Mylan shareholders "to a problematic...
  • Mylan rejects Teva's $40.1 billion buyout offer

    Mylan N.V. rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company. Mylan said that it won't think about starting talks unless Teva offers more than $100 per share, far above its current offer...
  • Most states list deadly methadone as a 'preferred drug'

    WASHINGTON As prescription drug overdose deaths soar nationwide, most states have failed to take a simple step that would make it harder for doctors to prescribe the deadliest of all narcotics. Methadone overdoses kill about 5,000 people every year,...